Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants
Kieren A. Marr(Freedom to Live), Lawrence Corey(Fred Hutch Cancer Center), Michael Boeckh(Fred Hutch Cancer Center), Benjamin Musher(Baylor College of Medicine), Wendy M. Leisenring(The University of Texas MD Anderson Cancer Center), Fulvio Crippa(Fred Hutch Cancer Center), S. Arunmozhi Balajee(PES University), W. Garrett Nichols(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Maggie Hoyle(Fred Hutch Cancer Center)
Cited by 442
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2015|4k
Chronic Health Conditions in Adult Survivors of Childhood Cancer
|New England Journal of Medicine|2006|3.6k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2016|2.8k